Overview
Hematopoietic Stem Cell Transplantation (HSCT) is a specialized form of blood stem cell transplant therapy. The term hematopoietic refers to the function of the stem cells in human beings. ‘Stem cell’ refers to specialized stem cell types which are capable of developing into specific cells like bone, muscle, blood, and nerve cells.
The global hematopoietic stem cell transplantation market is estimated to be valued at US$ 2,092.6 million in 2020 and is expected to exhibit a CAGR of 11.2% during the forecast period (2020-2027), as highlighted in a new report published by Coherent Market Insights.
Global Hematopoietic Stem Cell Transplantation (HSCT) Market: Drivers
High prevalence of leukemia, lymphoma, or myeloma is expected to propel growth of the global hematopoietic stem cell transplantation (HSCT) market over the forecast period. For instance, around 176,200 individuals in the U.S. were diagnosed with leukemia, lymphoma or myeloma and approximately 1,399,180 individuals were living with leukemia, lymphoma or myeloma, according to Leukemia and Lymphoma Societyโs 2019 report.
Moreover, high prevalence of cancer is also expected to propel growth of the global hematopoietic stem cell transplantation (HSCT) market over the forecast period. For instance, according to the World Health Organization, around 18.1 million new cases and 9.6 million deaths were registered due to cancer worldwide in 2018.
๐๐๐ญ ๐ ๐ฎ๐ฅ๐ฅ ๐๐๐ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐จ๐ฉ๐ฒ ๐จ๐ ๐๐๐ฉ๐จ๐ซ๐ญ: (๐๐ง๐๐ฅ๐ฎ๐๐ข๐ง๐ ๐ ๐ฎ๐ฅ๐ฅ ๐๐๐, ๐๐ข๐ฌ๐ญ ๐จ๐ ๐๐๐๐ฅ๐๐ฌ & ๐ ๐ข๐ ๐ฎ๐ซ๐๐ฌ, ๐๐ก๐๐ซ๐ญ) @ https://www.coherentmarketinsights.com/insight/request-pdf/1250
Recent Developments
Major players operating in the global hematopoietic stem cell transplantation (HSCT) market are focused on adopting partnership strategies to enhance their market share. For instance, in December 2017, Plasticell collaborated with Anthony Nolan, a blood cancer research organization, for R&D in Plasticellโs ex vivo expanded cord blood-derived hematopoietic stem cell product.
Covid-19 Impact Analysis
According to the guidelines issued by European Society for Blood and Marrow Transplantation (EMBT) for post HSCT and post CAR-T cell recipients: March 23, 2020, the individuals coming in contact with the recipient and donors are expected to maintain social distancing, travel by private car, wash hands, and others. If the recipient is tested positive for COVID-19, then the patient should be evaluated and treated for the same, by following all the guidelines.
According to the article published in National Center for Biotechnology Information (NCBI) on May 4, 2020, if the recipient contracts or comes in contact with the coronavirus infected person, then the stem cell transplant procedure should be postponed, till the person is tested negative after two repeated RT-PCR tests.
Market Trends
Major players operating in the global hematopoietic stem cell transplantation (HSCT) market are focused on adopting partnership strategies to enhance their market share. For instance, in March 2017, Plasticell partnered with Nan yang Technological University (NTU) in Singapore for R&D in therapeutic stem cell pipeline.
๐๐จ ๐๐๐ญ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ฉ๐จ๐ซ๐ญ ๐ฐ๐ข๐ญ๐ก ๐๐๐ญ๐๐ฌ๐ญ ๐๐จ๐ฏ๐ข๐๐๐ ๐๐ฆ๐ฉ๐๐๐ญ ๐๐ง๐๐ฅ๐ฒ๐ฌ๐ข๐ฌ @ https://www.coherentmarketinsights.com/insight/request-sample/1250
Hematopoietic Stem Cell Transplantation (HSCT) Market- Restraints
Side effects of hematopoietic stem cell transplantation on organs and body parts such as gastrointestinal tract, mouth, heart, lungs which are associated with the conditioning regimen and others and serious complication of graft vs. host disease are expected to hinder growth of the global hematopoietic stem cell transplantation market.
Global Hematopoietic Stem Cell Transplantation (HSCT) Market: Competitive Landscapeย ย
Major players operating in the global hematopoietic stem cell transplantation (HSCT) market include, Bluebird Bio, CellGenix GmbH, Escape Therapeutics, Inc., Kiadis Pharma, Lonza Group, Marker Therapeutics Inc., Pluristem Therapeutics Inc., Regen Biopharma Inc., Stempeutics Research Pvt Ltd., Taiga Biotechnologies, Inc., Takeda Pharmaceutical Company Limited, and Talaris Therapeutics, Inc.ย
Global Hematopoietic Stem Cell Transplantation (HSCT) Market: Competitive Landscapeย ย
Major players operating in the global hematopoietic stem cell transplantation (HSCT) market are focused on adopting partnership strategies to enhance their market share. For instance, in January 2019, Gamida Cell Ltd. partnered with Lonza for commercial production after the U.S. Food and Drug Administrationโs approval of omidubicel, designed to enhance the life-saving benefits of hematopoietic stem cell (bone marrow) transplant.
๐๐ฎ๐ฒ ๐๐จ๐ฐ ๐๐ง๐ ๐๐๐ญ ๐ ๐ฅ๐๐ญ ๐๐๐ ๐๐๐๐ ๐๐ ๐
๐๐ฎ๐ซ๐๐ก๐๐ฌ๐ ๐๐ก๐ข๐ฌ ๐๐ซ๐๐ฆ๐ข๐ฎ๐ฆ ๐๐๐ฉ๐จ๐ซ๐ญ ๐๐จ ๐๐๐๐๐ฌ๐ฌ ๐ ๐ฎ๐ฅ๐ฅ ๐๐ง๐๐จ๐ซ๐ฆ๐๐ญ๐ข๐จ๐ง @ https://www.coherentmarketinsights.com/promo/buynow/1250
Table Of Contents:
- Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- Market Overview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Transplant Type
- Market Snippet, By Indication
- Market Snippet, By Application
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Key Developments
- Pipeline Analysis
- PEST Analysis
- Reimbursement Scenario
- Regulatory Scenario
- Epidemiology
- Government Initiatives
- Treatment Algorithm
- Market Dynamics
- Global Hematopoietic Stem Cell Transplantation (HSCT) Market – Impact of Coronavirus (Covid-19) Pandemic
- COVID-19 Epidemiology
- Guidelines for COVID-19 Management in Hematopoietic Stem Cell Transplantation (HSCT)
- Impact of COVID-19 on Clinical Trials
- Global Hematopoietic Stem Cell Transplantation (HSCT) Market, By Transplant Type, 2016 โ 2027, (US$ Million)
- Introduction
- Market Share Analysis, 2020 and 2027 (%)
- Y-o-Y Growth Analysis, 2017 โ 2027
- Segment Trends
- Autologous
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 โ 2027, (US$ Million)
- Allogeneic
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 โ 2027, (US$ Million)
- Introduction
- Global Hematopoietic Stem Cell Transplantation (HSCT) Market, By Indication, 2016 โ 2027, (US$ Million)
- Introduction
- Market Share Analysis, 2020 and 2027 (%)
- Y-o-Y Growth Analysis, 2017 โ 2027
- Segment Trends
- Acute Myeloid Leukemia (AML)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 โ 2027, (US$ Million)
- Acute Lymphoblastic Leukemia (ALL)
- Introduction
- Size and Forecast, and Y-o-Y Growth, 2016 โ 2027, (US$ Million)
- Hodgkin lymphoma (HL)
- Introduction
- Size and Forecast, and Y-o-Y Growth, 2016 โ 2027, (US$ Million)
- Non-Hodgkin Lymphoma (NHL)
- Introduction
- Size and Forecast, and Y-o-Y Growth, 2016 โ 2027, (US$ Million)
- Multiple Myeloma (MM)
- Introduction
- Size and Forecast, and Y-o-Y Growth, 2016 โ 2027, (US$ Million)
- Other Non-malignant Disorders
- Introduction
- Size and Forecast, and Y-o-Y Growth, 2016 โ 2027, (US$ Million)
- Introduction
- Global Hematopoietic Stem Cell Transplantation (HSCT) Market, By Application, 2016 โ 2027, (US$ Million)
- Introduction
- Market Share Analysis, 2020 and 2027 (%)
- Y-o-Y Growth Analysis, 2017 โ 2027
- Segment Trends
- Bone Marrow Transplant (BMT)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 โ 2027, (US$ Million)
- Peripheral Blood Stem Cells Transplant (PBSCT)
- Introduction
- Size and Forecast, and Y-o-Y Growth, 2016 โ 2027, (US$ Million)
- Cord Blood Transplant (CBT)
- Introduction
- Size and Forecast, and Y-o-Y Growth, 2016 โ 2027, (US$ Million)
- Introduction
View Press Release: https://www.coherentmarketinsights.com/press-release/hematopoietic-stem-cell-transplantation-market-3658
About US:
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Contact Us:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837